Kevin Kabler concentrates his practice on patent prosecution, intellectual property due diligence, patent analysis, and strategic patent counseling for academic, venture capital and biotechnology clients.
Among the technologies with which Kevin has experience are siRNA, clean-tech, stem cells, immunotherapy, monoclonal antibodies, small molecules, polypeptides, oligonucleotides, viruses, vaccines, transgenic animals, and microarrays.
In 2007, Kevin began his career at Fenwick & West as a patent agent. Prior to joining Fenwick & West, Kevin was a postdoctoral fellow in the lab of Nobel Laureate J. Michael Bishop at the University of California, San Francisco.
Kevin is a co-inventor on multiple patents and has published numerous scientific papers in leading peer-reviewed journals including Nature Medicine and Nature Biotechnology.